EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. 2013

L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Understanding tumor-induced angiogenesis is a challenging problem with important consequences for the diagnosis and treatment of cancer. In this study, we define a novel function for epithelial membrane protein-2 (EMP2) in the control of angiogenesis. EMP2 functions as an oncogene in endometrial cancer, and its expression has been linked to decreased survival. Using endometrial cancer xenografts, modulation of EMP2 expression resulted in profound changes to the tumor microvasculature. Under hypoxic conditions, upregulation of EMP2 promoted vascular endothelial growth factors (VEGF) expression through a HIF-1α-dependent pathway and resulted in successful capillary-like tube formation. In contrast, reduction of EMP2 correlated with reduced HIF-1α and VEGF expression with the net consequence of poorly vascularized tumors in vivo. We have previously shown that targeting of EMP2 using diabodies in endometrial cancer resulted in a reduction of tumor load, and since then we have constructed a fully human EMP2 IgG1. Treatment of endometrial cancer cells with EMP2-IgG1 reduced tumor load with a significant improvement in survival. These results support the role of EMP2 in the control of the tumor microenvironment and confirm the cytotoxic effects observed by EMP2 treatment in vivo.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
November 2009, Molecular and cellular biochemistry,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
January 2014, International journal of clinical and experimental pathology,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
November 2018, European review for medical and pharmacological sciences,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
June 2012, Angiogenesis,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
July 2010, Carcinogenesis,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
June 2012, Developmental dynamics : an official publication of the American Association of Anatomists,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
September 2016, Oncogene,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
September 2011, Angiogenesis,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
May 2016, International heart journal,
L K Gordon, and M Kiyohara, and M Fu, and J Braun, and P Dhawan, and A Chan, and L Goodglick, and M Wadehra
December 2021, Cell biology international,
Copied contents to your clipboard!